Ligand validation:1OBH

NVA: NORVALINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1OBH_NVA_A_1816	59%	76%	0.138	0.943	0.53	0.41	-	-	0	0	88%	0.875
1OBH_NVA_A_1818	28%	89%	0.242	0.917	0.46	0.18	-	-	0	0	88%	0.875
1OBC_NVA_A_1815	53%	83%	0.149	0.934	0.56	0.23	-	-	0	0	88%	0.875
2BTE_NVA_D_1894	36%	83%	0.234	0.952	0.46	0.32	-	-	0	0	88%	0.875
2I6U_NVA_A_600	92%	57%	0.085	0.977	0.66	0.98	-	-	0	0	100%	1
6W3T_NVA_B_301	90%	32%	0.087	0.971	0.96	1.71	-	2	0	0	100%	1
4NF2_NVA_B_402	78%	41%	0.119	0.963	1.02	1.26	-	1	0	0	100%	1
1C9Y_NVA_A_355	75%	53%	0.133	0.966	1.03	0.78	1	-	0	0	100%	1
5ZEF_NVA_A_301	55%	14%	0.144	0.912	0.99	2.79	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.